|
67
|
182
|
5qi7A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000506a |
|
69
|
182
|
5qi0A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000352a |
|
68
|
182
|
5qi4A |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000466a |
|
66
|
182
|
5qi2A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000110a |
|
1
|
47
|
5zqpB |
Tankyrase-2 in complex with compound 12 |
|
70
|
182
|
5qhyA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000462a |
|
67
|
182
|
5qiaA |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000242a |
|
67
|
182
|
5qi1A |
Pandda analysis group deposition of models with modelled events (e.g. bound ligands) -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000474a |
|
69
|
182
|
5qhtA |
Pandda analysis group deposition -- crystal structure of human parp14 macrodomain 3 in complex with fmopl000065a |
|
31
|
116
|
6f5fA |
Structure of artd2/parp2 wgr domain bound to double strand dna with 5 nucleotide overhang and 5'phosphate |
|
49
|
191
|
5lxpA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor h5 |
|
51
|
191
|
5lx6A |
Human parp10 (artd10), catalytic fragment in complex with parp inhibitor veliparib |
|
49
|
190
|
5lyhA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor h10 |
|
109
|
350
|
5kppA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
17
|
58
|
5kniA |
Crystal structure of the wild-type sam domain of human tankyrase-1 |
|
107
|
352
|
5kpoA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
18
|
60
|
5ju5A |
Crystal structure of the human tankyrase 1 (tnks) sam domain (d1055r), crystal form 1 |
|
20
|
63
|
5jtiA |
Crystal structure of the human tankyrase 1 (tnks) sam domain (d1055r), crystal form 2 |
|
22
|
64
|
5jrtA |
Crystal structure of the human tankyrase 2 (tnks2) sam domain (dh902/924re) |
|
33
|
159
|
5fpfA |
Crystal structure of human tankyrase 2 in complex with ta-91 |
|
46
|
162
|
5adsA |
Crystal structure of human tankyrase 2 in complex with od39 |
|
46
|
162
|
5adrA |
Crystal structure of human tankyrase 2 in complex with od38 |
|
45
|
162
|
5adqA |
Crystal structure of human tankyrase 2 in complex with jw55 |
|
52
|
189
|
6g0wA |
Human parp14 (artd8), catalytic fragment in complex with inhibitor mcd72 |
|
52
|
197
|
6ek3A |
Parp15 catalytic domain mutant (y598l) in complex with oul35 |
|
123
|
320
|
6cf6A |
Rnf146 tbm-tankyrase arc2-3 complex |
|
63
|
246
|
6bhvA |
Human parp-1 bound to nad+ analog benzamide adenine dinucleotide (bad) |
|
101
|
349
|
5xsrA |
Novel orally efficacious inhibitors complexed with parp1 |
|
114
|
352
|
5wryA |
Structure of human parp1 catalytic domain bound to a quinazoline-2,4(1h,3h)-dione inhibitor |
|
114
|
352
|
5wrzA |
Structure of human parp1 catalytic domain bound to a phthalazinone inhibitor |
|
107
|
352
|
5ws0A |
Structure of human parp1 catalytic domain bound to a benzoimidazole inhibitor |
|
52
|
160
|
5bxoA |
Human tankyrase-2 in complex with macrocyclised extended peptide cp4n2m3 |
|
48
|
162
|
5c5pA |
Crystal structure of human tankyrase-2 in complex with a pyranopyridone inhibitor |
|
50
|
163
|
5bxuA |
Human tankyrase-2 in complex with macrocyclised extended peptide cp4n4m5 |
|
1
|
46
|
5adtB |
Crystal structure of human tankyrase 2 in complex with od73 |
|
1
|
46
|
5adqB |
Crystal structure of human tankyrase 2 in complex with jw55 |
|
1
|
46
|
5adrB |
Crystal structure of human tankyrase 2 in complex with od38 |
|
45
|
162
|
5adtA |
Crystal structure of human tankyrase 2 in complex with od73 |
|
110
|
290
|
5a3cA |
Crystal structure of the adp-ribosylating sirtuin (sirtm) from streptococcus pyogenes in complex with nad |
|
108
|
290
|
5a3aA |
Crystal structure of the adp-ribosylating sirtuin (sirtm) from streptococcus pyogenes (apo form) |
|
112
|
353
|
4zzyA |
Structure of human parp2 catalytic domain bound to an isoindolinone inhibitor |
|
106
|
290
|
5a3bA |
Crystal structure of the adp-ribosylating sirtuin (sirtm) from streptococcus pyogenes in complex with adp-ribose |
|
113
|
353
|
4zzzA |
Structure of human parp1 catalytic domain bound to an isoindolinone inhibitor |
|
48
|
155
|
4z68A |
Hybrid structural analysis of the arp2/3 regulator arpin identifies its acidic tail as a primary binding epitope |
|
64
|
199
|
4tk0A |
Crystal structure of human tankyrase 2 in complex with dpq. |
|
68
|
210
|
4uhgA |
Crystal structure of human tankyrase 2 in complex with ta-21 |
|
48
|
189
|
4f1qA |
Human artd8 (parp14, bal2) - catalytic domain in complex with a16(e) |
|
49
|
187
|
4f1lA |
Human artd8 (parp14, bal2) - catalytic domain in complex with inhibitor a16(z) |
|
49
|
198
|
4f0eA |
Human adp-ribosyltransferase 7 (artd7/parp15), catalytic domain in complex with sto1102 |
|
66
|
270
|
4f0dA |
Human artd15/parp16 in complex with 3-aminobenzamide |
